AVI Polymers Limited has announced the launch of AVI AI Technologies Private Limited, a wholly owned subsidiary focused on developing AI-driven personal healthcare solutions for India's rapidly evolving digital health ecosystem. The company disclosed this strategic expansion through a press release on March 16, 2026, under Regulation 30 of SEBI listing requirements.

Subsidiary Formation and Strategic Focus

The new subsidiary, AVI AI Technologies Private Limited, was incorporated on February 18, 2026, with a refined focus on personal healthcare AI solutions designed specifically for the Indian market:

Product Development Vision

The subsidiary aims to develop accessible, intelligent, mobile-first healthcare technology platforms supporting preventive care, wellness tracking, early risk identification, and personalized health engagement. The company plans to address India's growing digital healthcare adoption driven by increasing smartphone penetration, rising health awareness, and telemedicine growth.

Proposed Healthcare AI Features

AVI AI Technologies Private Limited is developing a comprehensive suite of personal healthcare AI products that may include:

Market Opportunity and Technology Strategy

The subsidiary represents AVI Polymers' strategic entry into AI-powered personal healthcare, focusing on creating India-centric solutions that are practical, scalable, and relevant to everyday users. The company believes AI will play an increasingly important role in healthcare by improving personalization, efficiency, outreach, and decision support.

The long-term objective involves creating digital products that enhance engagement, accessibility, preventive awareness, and intelligent healthcare support for millions of users across India. The initiative combines artificial intelligence, predictive analytics, multilingual conversational interfaces, and data-led wellness insights to deliver an intuitive user experience.

Corporate Governance and Compliance

The disclosure was made by Chintan Yashwantbhai Patel, Managing Director (DIN: 10774473), ensuring compliance with SEBI listing obligations. The company emphasized that this strategic initiative aligns with its commitment to building future-oriented growth opportunities across innovation-led sectors through technology-oriented initiatives and scalable business platforms.

Avi Polymers has announced its strategic entry into the AI-driven personal healthcare market, marking a significant expansion beyond its traditional polymer manufacturing operations. This move represents the company's diversification strategy into emerging technology sectors.

Strategic Business Expansion

The company's decision to enter the AI-driven personal healthcare market demonstrates its commitment to exploring new growth opportunities in technology-enabled sectors. This expansion marks a departure from Avi Polymers' conventional focus on polymer manufacturing and processing.

Market Positioning

By entering the AI-driven personal healthcare space, Avi Polymers is positioning itself to capitalize on the growing intersection of artificial intelligence and healthcare services. The personal healthcare market has seen increased adoption of AI-powered solutions for various health monitoring and management applications.

Business Diversification

This strategic move reflects the company's broader diversification efforts, expanding its operational scope beyond traditional polymer products. The entry into AI-driven healthcare represents a significant shift toward technology-oriented business segments for the manufacturing company.